Check-Cap Ltd.
CHEK
Price:
$0.59
Market Cap:
$3.45M
Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. The company was incorporated in 2004 and is based in Is...[Read more]
Industry
Medical - Diagnostics & Research
IPO Date
2015-03-04
Stock Exchange
NASDAQ
Ticker
CHEK
PE Ratio
[-0.20]
ROE
[-48.45%]
Current Ratio
[18.69]
Dividend Yield
[0%]
Enterprise Value
[-5392288.00]
Dividend History
The ROE as of December 2024 (TTM) for Check-Cap Ltd. (CHEK) is -48.45%
According to Check-Cap Ltd.’s latest financial reports and current stock price. The company's current ROE is -48.45%. This represents a change of 230.87% compared to the average of -14.64% of the last 4 quarters.
Check-Cap Ltd. (CHEK) Historical ROE (quarterly & annually)
How has CHEK ROE performed in the past?
The mean historical ROE of Check-Cap Ltd. over the last ten years is -106.83%. The current -48.45% ROE has changed -54.65% with respect to the historical average. Over the past ten years (40 quarters), CHEK's ROE was at its highest in in the June 2014 quarter at 117.73%. The ROE was at its lowest in in the September 2017 quarter at -141.58%.
Average
-106.83%
Median
-84.41%
Minimum
-218.09%
Maximum
-33.72%
Check-Cap Ltd. (CHEK) ROE by Quarter and Year
Discovering the peaks and valleys of Check-Cap Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 168.37%
Maximum Annual ROE = -33.72%
Minimum Annual Increase = -61.47%
Minimum Annual ROE = -218.09%
| Year | ROE | Change |
|---|---|---|
| 2023 | -74.17% | 59.14% |
| 2022 | -46.61% | 38.22% |
| 2021 | -33.72% | -59.87% |
| 2020 | -84.02% | -61.47% |
| 2019 | -218.09% | 168.37% |
| 2018 | -81.27% | -50.89% |
| 2017 | -165.47% | 95.11% |
| 2016 | -84.81% | -12.72% |
| 2015 | -97.17% | -46.91% |
| 2014 | -183.03% | -45.44% |
Check-Cap Ltd. (CHEK) Average ROE
How has CHEK ROE performed in the past?
The current ROE of Check-Cap Ltd. (CHEK) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-51.50%
5-year avg
-91.32%
10-year avg
-106.83%
Check-Cap Ltd. (CHEK) ROE vs. Peers
How is CHEK’s ROE compared to its peers?
Check-Cap Ltd.’s ROE is less than FONAR Corporation (5.78%), greater than Burning Rock Biotech Limited (-60.83%), greater than Sera Prognostics, Inc. (-51.73%), greater than Olink Holding AB (publ) (-7.07%), greater than LumiraDx Limited (-1557.76%), less than Genetron Holdings Limited (0%), greater than Psychemedics Corporation (-49.63%), greater than DarioHealth Corp. (-52.70%), greater than Biodesix, Inc. (-277.36%), greater than Aclaris Therapeutics, Inc. (-26.28%), less than Castle Biosciences, Inc. (1.47%), greater than Prenetics Global Limited (-25.37%), greater than Neuronetics, Inc. (-160.79%), greater than MDxHealth SA (-1163.85%), greater than Inotiv, Inc. (-53.29%),
| Company | ROE | Market cap |
|---|---|---|
| 5.78% | $94.95M | |
| -60.83% | $65.57M | |
| -51.73% | $288.03M | |
| -7.07% | $3.24B | |
| -1557.76% | $0 | |
| 0% | $127.29M | |
| -49.63% | $15.74M | |
| -52.70% | $27.28M | |
| -277.36% | $228.38M | |
| -26.28% | $194.29M | |
| 1.47% | $771.04M | |
| -25.37% | $68.97M | |
| -160.79% | $44.58M | |
| -1163.85% | $111.86M | |
| -53.29% | $106.14M |
Build a custom stock screener for Check-Cap Ltd. (CHEK) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Check-Cap Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Check-Cap Ltd. (CHEK) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Check-Cap Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Check-Cap Ltd.'s ROE?
How is the ROE calculated for Check-Cap Ltd. (CHEK)?
What is the highest ROE for Check-Cap Ltd. (CHEK)?
What is the 3-year average ROE for Check-Cap Ltd. (CHEK)?
What is the 5-year average ROE for Check-Cap Ltd. (CHEK)?
How does the current ROE for Check-Cap Ltd. (CHEK) compare to its historical average?